| Hans-Günter Meyer-Thompson | Opioide
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse
FDA releases adverse events and scientific analysis providing even stronger evidence of kratom compounds’ opioid properties. (FDA – Food and Draug administration, 06.02.2018)
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm595622.htm